Found 11 matching trials
Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms PHASE1 P276-00 is specific Cdk4-D1 and Cdk1-B inhibitor. P276-00 exhibited signifi...
Show More Location
Juravinsky Cancer Centre
Learn More & Join Trial
A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer PHASE2 This is a single arm phase II trial to study the efficacy and safety of a C...
Show More Location
Bharath Hospital & Institute of Oncology, Mysore
Learn More & Join Trial
A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin PHASE1 P276-00 is a novel, potent, small-molecule, flavone-derived Cdk 4 D1, Cdk1 ...
Show More Location
Disney Cancer Center
Learn More & Join Trial
Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma PHASE1 This research study is a Phase I/II clinical trial. It is done to determine...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer PHASE1 The purpose of this study is to identify a dose of P276-00 that can be safe...
Show More Location
Central India Cancer Research Institute
Learn More & Join Trial
Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression PHASE2 The purpose of this study is to evaluate efficacy of P276-00 in subjects wi...
Show More Location
University of Newcastle, School of Medicine and Public Health
Learn More & Join Trial
A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma PHASE2 The purpose of this study is to determine whether P276-00 is safe and effec...
Show More Location
Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona
Learn More & Join Trial
A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00 PHASE2 A Clinical Study to Assess Radiation Induced Mucositis in Subjects with Loc...
Show More Location
Bharat Cancer Hospital & Research Institute
Learn More & Join Trial
Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms PHASE1 P276-00 is a molecule derived from Rohitukine, which through pre clinical a...
Show More Location
Nizam's Institute of Medicai Sciences
Learn More & Join Trial
Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma PHASE1 The purpose of this study is to determine safety of P276-00 in patients wit...
Show More Location
Jaslok Hospital & Research Centre
Learn More & Join Trial